Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYRE | ABVX | MIRM | ||
| Company | Spyre Therapeutics Inc | Abivax Sa ADR | Mirum Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 91.00 | 93.01 | 116.51 | ||
| High | 91.00 | 99.23 | 124.44 | ||
| Low | 85.97 | 93.01 | 113.41 | ||
| Latest | 87.89 | 97.50 | 123.77 | ||
| Change | -0.78 | +5.13 | +6.49 | ||
| % Change | -0.88% | +5.55% | +5.53% | ||
| Volume | 4,441,200 | 1,666,900 | 3,372,700 | ||
| 20-Day Average Volume | 1,772,875 | 3,466,475 | 1,061,525 | ||
| Previous Close | 88.67 | 92.37 | 117.28 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 81.35 | 100.43 | 101.82 | ||
| 20-Day Raw Stochastic | 57.78% | 43.48% | 98.02% | ||
| 20-Day Relative Strength | 58.91 | 44.68 | 72.73 | ||
| Weighted Alpha | +399.00 | +76.47 | +141.57 | ||
| Today's Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 88% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.51% since 06/18/26 | -1.66% since 06/18/26 | +15.53% since 06/18/26 | ||
| Low | 81.65 on 06/24/26 | 74.79 on 06/24/26 | 105.18 on 06/23/26 | ||
| High | 102.06 on 06/23/26 | 103.83 on 06/22/26 | 124.44 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +19.33% since 05/26/26 | -22.87% since 05/26/26 | +25.15% since 05/26/26 | ||
| Low | 68.50 on 06/02/26 | 69.81 on 06/02/26 | 90.59 on 06/03/26 | ||
| High | 102.06 on 06/23/26 | 135.07 on 05/28/26 | 124.44 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | +84.95% since 03/26/26 | -10.94% since 03/26/26 | +39.26% since 03/26/26 | ||
| Low | 44.80 on 03/30/26 | 69.81 on 06/02/26 | 86.97 on 03/31/26 | ||
| High | 102.06 on 06/23/26 | 135.07 on 05/28/26 | 124.44 on 06/26/26 | ||
| 6-Month | |||||
| %Chg | +166.82% since 12/26/25 | -31.49% since 12/26/25 | +56.16% since 12/26/25 | ||
| Low | 28.00 on 01/05/26 | 69.81 on 06/02/26 | 73.82 on 01/05/26 | ||
| High | 102.06 on 06/23/26 | 147.00 on 12/29/25 | 124.44 on 06/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,632,456 | 7,777,574 | 7,547,617 | ||
| Shares Outstanding, K | 86,841 | 79,770 | 60,981 | ||
| Annual Sales | 0 | 0 | 521,310,000 | ||
| Annual Net Income | -155,200,000 | -380,270,000 | -23,360,000 | ||
| Last Quarter Sales | 0 | 0 | 159,880,000 | ||
| Last Quarter Net Income | -69,010,000 | -56,730,000 | -790,160,000 | ||
| 60-Month Beta | 3.05 | 0.69 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/05/26 | -0.71 on 05/22/26 | -0.39 on 05/06/26 | ||
| Earnings Date | 08/04/26 | 09/14/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||